Polymedco, Inc. / Polymedco Cancer Diagnostic Products recalls

Polymedco, Inc. / Polymedco Cancer Diagnostic Products has 4 recalls on record with the FDA and USDA, the earliest in 2018 and the latest reported on 14 Oct 2026. 2 are still ongoing. 2 were reported in the last 12 months. The most frequent reason is packaging defects.

Total recalls4since 2018

Last 12 months2reported

Class I00% of total

Ongoing2latest 14 Oct 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 1Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 1

Severity split

Class I 0 0%Class II 3 75%Class III 1 25%

Why polymedco, inc. / polymedco cancer diagnostic products is recalled

Product types

By year

2026125%
2025125%
2018250%

Ongoing polymedco, inc. / polymedco cancer diagnostic products recalls

2 active

Reported	Class	Recall	Company	Reason	Where
14 Oct 2026Device	CLASS II	Sediplast; Model/Catalog Numbers recalled by Polymedco, Inc. / Polymedco	Polymedco, Inc. / Polymedco Cancer Diagnostic Products	Other	Nationwide
26 Nov 2025Device	CLASS III	OC-Auto Fobt-chek Negative Controls is the negative recalled	Polymedco, Inc. / Polymedco Cancer Diagnostic Products	Labeling Errors	47 states

All polymedco, inc. / polymedco cancer diagnostic products recalls, newest first

4 total

Reported	Class	Recall	Company	Reason	Where
14 Oct 2026Device	CLASS II	Sediplast; Model/Catalog Numbers recalled by Polymedco, Inc. / Polymedco	Polymedco, Inc. / Polymedco Cancer Diagnostic Products	Other	Nationwide
26 Nov 2025Device	CLASS III	OC-Auto Fobt-chek Negative Controls is the negative recalled	Polymedco, Inc. / Polymedco Cancer Diagnostic Products	Labeling Errors	47 states
26 Sep 2018Device	CLASS II	Pathfast NTproBNP recalled by Polymedco, Inc.,/Polymedco	Polymedco, Inc.,/Polymedco Cancer Diagnostic Products	Packaging Defects	8 states
26 Sep 2018Device	CLASS II	Pathfast Myoglobin II reagent cartridge recalled	Polymedco, Inc.,/Polymedco Cancer Diagnostic Products	Packaging Defects	8 states

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.